Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-sparing analgesia after thoracotomy
PACTR202104609519383Phase 3Recruiting
- Sponsor
- Dr mona raafat elghamry
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nalbuphine in postoperative pain (2 arms), sponsored by Dr mona raafat elghamry. Primary endpoint: Postoperative morphine consumption. Started May 2021; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202104609519383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202104609519383.